Browse Studies — Arctuva

Observational

Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

Mesothelioma

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT03683680

Observational

A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)

This is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SM…

Pancreas CancerLung CancerRenal Cancer+10 more

Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT04115254

Phase 1

FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma

This is a first in human phase 1 study of AG01 an anti-Progranulin/Glycoprotein88 (PGRN/GP88) antibody in patients with advanced solid tumors. AG01 is a recomb…

Triple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung Cancer+1 more

Estimated

~$10 – $8,750

A&G Pharmaceutical Inc.NCT05627960